Viatris Inc (VTRS) Form 8-K — Oct 8, 2026
Viatris entered into a merger agreement on October 8, 2026 to acquire Pacira BioSciences through an all-cash tender offer at $36.50 per share, followed by a merger under DGCL Section 251(h) with no Pacira stockholder vote required. The offer is subject to a minimum condition that shares representing more than 50% of Pacira's outstanding stock be tendered, HSR clearance, and other customary conditions, with no financing condition. Pacira's board unanimously approved the deal and recommends shareholders tender; Pacira owes Viatris a $62 million termination fee in specified circumstances.
Key figures
- Offering Price
- 36.5
- Shares Outstanding
- 39912226
- Outside date
- April 8, 2027 (auto-extension to July 8, 2027)
- Offer duration
- 10 business days
- Offer minimum condition
- majority of shares tendered
- Termination fee payable by pacira
- $62,000,000
- Pacira convertible notes principal
- $287,500,000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.